The largest pharmacy benefit manager in the country, Express Scripts (NASDAQ:ESRX), has seen its shares fall under serious pressure since reporting earnings. To keep investors up to speed with the stock, Motley Fool health care bureau chief Brenton Flynn breaks down some of the key changes to the company's latest SEC filings and compares his findings with the commentary from one of its big customers, UnitedHealth Group (NYSE:UNH).
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.